Pharmacokinetic and Pharmacodynamic Perspectives on the Clinical Drug Development of Panitumumab

By Yang Bing-Bing   Lum Peggy   Chen Alin   Arends Rosalin   Roskos Lorin   Smith Brian   Ruixo Juan José Pérez  

Clinical Pharmacokinetics, Vol. 49, Iss. 11, 2010-11 ,pp. : 729-740

Adis International

Access to resources Recommend Favorite

Pharmacogenomics in early-phase clinical development

By Burt Tal   Dhillon Savita  

Pharmacogenomics, Vol. 14, Iss. 9, 2013-07 ,pp. : 1085-1097

Future Medicine

Access to resources Recommend Favorite

A Pharmacokinetic–Pharmacodynamic Model of Chemotherapy of Human Immunodeficiency Virus Infection that Relates Development of Drug Resistance to Treatment Intensity

By Jackson Robert C.  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 25, Iss. 6, 1997-12 ,pp. : 713-730

Springer Publishing Company

Access to resources Recommend Favorite

Development of Biosimilars—Pharmacokinetic and Pharmacodynamic Considerations

By Wang Yow-Ming   Chow Andrew  

Journal of Biopharmaceutical Statistics, Vol. 20, Iss. 1, 2010-01 ,pp. : 46-61

Taylor & Francis Ltd

Access to resources Recommend Favorite

The Potential Use of Piglets as Human Pediatric Surrogate for Preclinical Pharmacokinetic and Pharmacodynamic Drug Testing

By  

Current Pharmaceutical Design, Vol. 22, Iss. 26, 2016-08 ,pp. : 4069-4085

Bentham Science Publishers

Access to resources Recommend Favorite